Tim Clackson, Ph.D.

Tim Clackson is a scientist and biotechnology leader with 30 years of experience building teams and companies, primarily in oncology. He has led the development of multiple precision medicines for cancer patients, including several approved therapies, and created significant value through strategic capital formation, partnerships, and M&A. Tim was most recently CEO of IDRx, a […]

Craig Gibbs, Ph.D., M.B.A.

Craig Gibbs, Ph.D., M.B.A. has been Chief Executive Officer and a Member of the Board of Vivace Therapeutics Inc. since May of 2026. He is also Chairman of the Board of Inipharm Inc. Previously he was Chief Executive Officer and Member of the Board of Asher Biotherapeutics Inc. from September of 2020 to September of […]

Edward Hu, M.B.A.

Mr. Hu is founding partner of WuXi Healthcare Ventures, and also chief financial officer and chief investment officer at WuXi AppTec, a leading global technology and capability platform company, providing integrated R&D services to the global pharmaceutical, biotech, and medical device industries. He formerly served as senior vice president and chief operating officer at Tanox, […]